Media Library
icon
-
PDFlockDisease education / Fact SheetHeart failure hospitalization: why this moment matters
Hospitalization provides an opportunity for physicians to optimize heart failure treatment to reduce the likelihood of hospital readmission and death, reduce the burden of hospitalizations, and improve outcomes for patients living with heart failure.
-
PDFlockDisease education / Fact SheetSpinal Muscular Atrophy (SMA) Factsheet
Novartis and AveXis combine, aiming to transform the care of SMA, the #1 genetic cause of infant mortality.
-
PDFlockCorporate Responsibility / Fact SheetStrengthening our Global Health & Corporate Responsibility function
The factsheet “Strengthening our Global Health & Corporate Responsibility function” provides an overview of our Global Health & Corporate Responsibility governance, structure, strategic priorities and commitments.
-
PDFlockCorporate Responsibility / Fact SheetBuilding trust with society: our priorities
The fact sheet “Building trust with society: our priorities” provides key highlights around 4 areas: pricing and access to medicines; global health challenges; ethical standards; and corporate responsibility.
-
PDFlockDisease Awareness / Fact SheetEarly versus Advanced Breast Cancer List
Although breast cancer is one of the most visible and supported diseases in the world, the majority of public focus goes toward prevention, early detection and survival.
-
PDFlockDisease Awareness / Fact SheetRenal Cell Carcinoma (RCC) Fact Sheet
Renal Cell Carcinoma (RCC) is the most common type of kidney cancer and accounts for 90% of all cancerous kidney tumors.
-
PDFlockDisease Awareness / Fact SheetChronic Myeloid Leukemia Today and Tomorrow Visual Fact Sheet
Global survey of Chronic Myeloid Leukemia (CML) treaters across 9 countries and 4 continents suggests many physicians are ambitiously managing the disease despite its chronic nature.
-
PDFlockCorporate Responsibility / Fact SheetNovartis Access fact sheet
This fact sheet provides information on Novartis Access, a social business model that brings affordable treatments to patients suffering from chronic diseases in low- and lower-middle-income countries (LMICs).
-
PDFlockDisease Awareness / Fact SheetChagas Disease
Reimagining the fight against Chagas disease: Although Chagas disease was discovered more than a century ago, it remains a major public health challenge – and current tools to fight the disease are outdated and inadequate.
-
PDFlockDisease Awareness / Fact SheetMalaria
Novartis has been in the front ranks of a revolution in the treatment of malaria, launching the first fixed-dose artemisinin-based combination therapy (ACT) in 1999 and the first dispersible pediatric ACT developed in partnership with Medicines for Malaria Venture (MMV) in 2009.
-
PDFlockDisease Awareness / Fact SheetReimagining the management of sickle cell disease in Africa
Reimagining the management of sickle cell disease in Africa. Sickle cell disease is a hereditary and life-threatening condition that causes ongoing vascular damage and repeated injury to blood vessels and organs. This lifelong illness often takes an extreme emotional, physical, and financial toll on patients and their families.
-
PDFlockDisease Awareness / Fact SheetLeprosy
The fight against leprosy is one of the greatest public health successes in history. For more than 30 years, Novartis and the Novartis Foundation have been working with partners around the world to eliminate leprosy.